Nara Organics Recalls Formula After Infant Botulism Cases

Nara Organics has issued a voluntary recall of its Whole Milk Organic Powdered Infant Formula following reports that three infants developed infant botulism after consuming the product. According to the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), the affected babies, aged between 2 and 5 months, were hospitalized in California, Washington, and Pennsylvania. All three children have since been successfully treated.

The recalled formula was sold at Target stores across the United States and online through Target.com and Nara.com. The FDA confirmed that the product is manufactured in Europe but distributed exclusively within the U.S., accounting for less than 1% of all infant formula sales nationwide, thus not posing a significant risk of shortages.

Infant botulism occurs when Clostridium botulinum spores colonize an immature gut, producing toxins that can lead to severe symptoms such as constipation, poor feeding, drooping eyelids, weak muscle tone, and difficulty breathing. The CDC emphasizes the importance of immediate medical attention if these symptoms appear in infants who have consumed the recalled formula. Treatment involves BabyBIG, an IV medication derived from blood plasma of individuals immunized against botulism.

The FDA has not found any lots of Nara Organics Powdered Infant Formula to test positive for Clostridium botulinum, but as a precautionary measure, the company is recalling all whole milk infant powdered formula products. The specific lot numbers involved are 709125280E14F2, 709125288E14F2, and 708125174E14F2. Customers who purchased the formula from Nara.com between May and June 2026 will receive automatic refunds, while others can request refunds online or return products to Target stores for reimbursement.

The CDC has advised parents to monitor their children for symptoms up to a month after consuming the formula, as symptoms of infant botulism can take several weeks to begin. Parents are also urged to seek immediate medical care if their infants show signs such as difficulty swallowing, poor feeding, loss of head control, or decreased facial expression.

Nara Organics issued a statement expressing sincere apologies for the concern and distress caused by this announcement. The company committed to transparency and accountability throughout the process as they work to identify further information. Consumers can find refund information on the company’s website, nara.com.